Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis.

Khouri R, Bafica A, Silva Mda P, Noronha A, Kolb JP, Wietzerbin J, Barral A, Barral-Netto M, Van Weyenbergh J.

J Immunol. 2009 Feb 15;182(4):2525-31. doi: 10.4049/jimmunol.0802860.

2.

Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR) via TLR2.

Vivarini Ade C, Pereira Rde M, Teixeira KL, Calegari-Silva TC, Bellio M, Laurenti MD, Corbett CE, Gomes CM, Soares RP, Silva AM, Silveira FT, Lopes UG.

FASEB J. 2011 Dec;25(12):4162-73. doi: 10.1096/fj.11-185165. Epub 2011 Aug 16.

PMID:
21846836
3.

SOD1 plasma level as a biomarker for therapeutic failure in cutaneous leishmaniasis.

Khouri R, Santos GS, Soares G, Costa JM, Barral A, Barral-Netto M, Van Weyenbergh J.

J Infect Dis. 2014 Jul 15;210(2):306-10. doi: 10.1093/infdis/jiu087. Epub 2014 Feb 7.

4.

Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania.

Gomes IN, Calabrich AF, Tavares Rda S, Wietzerbin J, de Freitas LA, Veras PS.

Microbes Infect. 2003 Apr;5(4):251-60.

PMID:
12706438
6.

Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection.

Giudice A, Vendrame C, Bezerra C, Carvalho LP, Delavechia T, Carvalho EM, Bacellar O.

BMC Infect Dis. 2012 Mar 29;12:75. doi: 10.1186/1471-2334-12-75.

7.

Transforming growth factor-beta in human cutaneous leishmaniasis.

Barral A, Teixeira M, Reis P, Vinhas V, Costa J, Lessa H, Bittencourt AL, Reed S, Carvalho EM, Barral-Netto M.

Am J Pathol. 1995 Oct;147(4):947-54.

8.

The iron-dependent mitochondrial superoxide dismutase SODA promotes Leishmania virulence.

Mittra B, Laranjeira-Silva MF, Miguel DC, Perrone Bezerra de Menezes J, Andrews NW.

J Biol Chem. 2017 Jul 21;292(29):12324-12338. doi: 10.1074/jbc.M116.772624. Epub 2017 May 26.

PMID:
28550086
9.
10.

Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide.

Mukbel RM, Patten C Jr, Gibson K, Ghosh M, Petersen C, Jones DE.

Am J Trop Med Hyg. 2007 Apr;76(4):669-75.

PMID:
17426168
11.

Leishmania (Viannia) braziliensis amastigotes from patients with mucosal leishmaniasis have increased ability to disseminate and are controlled by nitric oxide at the early stage of murine infection.

Gomes CM, Ávila LR, Santos JC, Oliveira PG, Tomé FD, Pereira LI, Dorta ML, Lino RS Jr, Ribeiro-Dias F, Oliveira MA.

Pathog Dis. 2016 Jun;74(4):ftw023. doi: 10.1093/femspd/ftw023. Epub 2016 Apr 11.

PMID:
27073255
12.

Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.

Santos DM, Petersen AL, Celes FS, Borges VM, Veras PS, de Oliveira CI.

PLoS Negl Trop Dis. 2014 Oct 23;8(10):e3275. doi: 10.1371/journal.pntd.0003275. eCollection 2014 Oct.

13.

Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.

Giudice A, Camada I, Leopoldo PT, Pereira JM, Riley LW, Wilson ME, Ho JL, de Jesus AR, Carvalho EM, Almeida RP.

BMC Infect Dis. 2007 Feb 22;7:7.

14.

An in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensis.

Gibson-Corley KN, Bockenstedt MM, Li H, Boggiatto PM, Phanse Y, Petersen CA, Bellaire BH, Jones DE.

PLoS One. 2014 Sep 5;9(9):e106426. doi: 10.1371/journal.pone.0106426. eCollection 2014.

15.

Role of protein kinase R in the killing of Leishmania major by macrophages in response to neutrophil elastase and TLR4 via TNFα and IFNβ.

Faria MS, Calegari-Silva TC, de Carvalho Vivarini A, Mottram JC, Lopes UG, Lima AP.

FASEB J. 2014 Jul;28(7):3050-63. doi: 10.1096/fj.13-245126. Epub 2014 Apr 14.

16.

DETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis.

Khouri R, Novais F, Santana G, de Oliveira CI, Vannier dos Santos MA, Barral A, Barral-Netto M, Van Weyenbergh J.

PLoS One. 2010 Dec 21;5(12):e14394. doi: 10.1371/journal.pone.0014394.

17.

Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.

Ricardo-Carter C, Favila M, Polando RE, Cotton RN, Bogard Horner K, Condon D, Ballhorn W, Whitcomb JP, Yadav M, Geister RL, Schorey JS, McDowell MA.

Parasite Immunol. 2013 Dec;35(12):409-20. doi: 10.1111/pim.12049.

18.

Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis.

Afonso L, Borges VM, Cruz H, Ribeiro-Gomes FL, DosReis GA, Dutra AN, Clarêncio J, de Oliveira CI, Barral A, Barral-Netto M, Brodskyn CI.

J Leukoc Biol. 2008 Aug;84(2):389-96. doi: 10.1189/jlb.0108018. Epub 2008 May 15.

PMID:
18483206
19.
20.

Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major.

Assreuy J, Cunha FQ, Epperlein M, Noronha-Dutra A, O'Donnell CA, Liew FY, Moncada S.

Eur J Immunol. 1994 Mar;24(3):672-6.

PMID:
8125136

Supplemental Content

Support Center